Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 5 | — | — |
COVID; COVID; second time tested positive for COVID; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOD-2025-782175 (Moderna). A patient (age and gender not provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Nov2022 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown), in Mar2021 as dose 2, single (Batch/Lot number: unknown), in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) and in Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "battled leukemia" (unspecified if ongoing), notes: for close to 10 years and was on a drug trial through. The patient's concomitant medications were not reported. Past drug history included: Protonix, reaction(s): "GERD"; Olmesartan, reaction(s): "high blood pressure", notes: 40 mg once daily; Amlodipine, reaction(s): "high blood pressure", notes: 10 mg once daily The following information was reported: DISEASE RECURRENCE (medically significant) with onset 2023, outcome "recovered", described as "second time tested positive for COVID"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID". The clinical course was reported as follows: The patient tested positive for COVID twice. The first time got COVID, took PAXLOVID and the PAXLOVID gave more side effects than the COVID virus did. The second time tested positive for COVID (at the end of 2023) they attempted to find a smaller/ pediatric dose of PAXLOVID but by the time they found it, no longer had any symptoms. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Leukemia (for close to 10 years and was on a drug trial through.)
Test Name: COVID; Test Result: Positive ; Test Date: 2023; Test Name: COVID; Test Result: Positive